CXCR4 and acute lymphoblastic leukemia: The combination of CXCR4 antagonists with tyrosine kinase inhibitor, chemotherapeutic agents and FLT3 inhibitors can effectively eradicate ALL cells in multiple PDX models.109, 110, 111, 112